All lanes : Anti-UBE2E3 antibody [4B4] (ab128098) at 1/2000 dilutionLane 1 : HEK293T cells were transfected with pCMV6-ENTRY control Lane 2 : HEK293T cells were transfected with pCMV6-ENTRY UBE2E3 cDNALysates/proteins at 5 µg per lane.
Flow cytometry analysis of HEK293T cells transfected with either UBE2E3 overexpressing plasmid in Red or empty vector control plasmid in Blue and immunostained by anti-UBE2E3 antibody (ab128098) at 1/100 dilution.
Flow cytometry analysis of Hela cells, using anti-UBE2E3 antibody (ab128098) in Red at 1/100 dilution, compared to a nonspecific negative control antibody in Blue.
Flow cytometry analysis of Jurkat cells, using anti-UBE2E3 antibody (ab128098) in Red at 1/100 dilution, compared to a nonspecific negative control antibody in Blue.
ab128098, at 1/100, staining UBE2E3 in COS7 cells transiently transfected with pCMV6-ENTRY UBE2E3 by immunofluorescence staining.
ab128098, at 1/150, staining UBE2E3 in Adenocarcinoma of Human endometrium tissue by immunohistochemistry [Paraffin Embedded Tissues (IHC-P)].